News Detail
New Delhi, 30 Dec 2023: The expert committee of the National Pharmaceutical Pricing Authority (NPPA) has recommended retail prices of 24 anti-diabetes drug combinations with components sitagliptin and dapagliflozin, which lost their exclusive patent rights for marketing in the co......
View Details
Source : Pharmabiz
NPPA
sitagliptin
dapagliflozin
patent rights
MDC
glimepiride
Abbott Healthcare
Lupin
Mankind Pharma
Glenmark
Emcure
Torrent
Eris Lifesciences
Dr Reddy’s Laboratories
Related News
- Fake degrees seized from pvt institute in Hisar (13-12-2024)
- Health ministry assign testing labs for surgical and medical examination gloves (13-12-2024)
- DCGI asks States to approve all applications for medicines and medical devices for rare diseases within three months (13-12-2024)
- Karnataka to restructure drugs control dept, strengthen procedures (13-12-2024)
- US FDA identifies cases of liver injury after treatment with Intercept's Ocaliva (obeticholic acid) (13-12-2024)
- Fake platelets sold for 15 thousand rupees in Prayagraj, CMO ordered an inquiry (12-12-2024)
- Cardiac drug sales signal increase in heart ailments (12-12-2024)
- Banned cough syrup worth Rs 15 lakh seized, driver arrested (12-12-2024)
- Sales in the respiratory market reached Rs 1,638 crore in November 2024 (12-12-2024)
- Kenya Govt Cautions Kenyans after Unregistered Cancer Drug Hits Market (12-12-2024)